Not Tagged
Not Tagged
['bet', 'pcnsl', '2019', 'lymphoma', 'lymsm', 'marker ']
impact of double expression myc/bcl2 on pcnsl outcome
poynton et al
- del n 40% cases (more than systemic)
- del assoc with worse pfs even in matrix rx subgroup
- possibly identifies group with separate biology
prognostic but not predictive - no data to rx diff
#ash22 #lymsm 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.